Блог

What do facial light studies tell us about fat loss?

They provide evidence about particular skin outcomes, rather than a direct test of facial fat preservation. This distinction matters in both directions: an improvement in wrinkles does not establish fat loss, and a trial that never measured fat cannot rule out every possible fat-related effect.

The 2014 controlled trial by Wunsch and Matuschka included 136 volunteers and compared large-area polychromatic light treatments with an untreated control group. It assessed skin feeling and complexion, surface roughness, photographic wrinkle ratings and ultrasound-derived intradermal collagen density. The ultrasound endpoint was not cheek fat thickness. Its gas-discharge and fluorescent light sources also differ from a typical narrow-band LED face mask. [1]

A 2025 randomized, double-blind trial enrolled 60 adults of Asian descent to evaluate a home mask combining 630 nm red and 850 nm near-infrared light against a lower-output sham. Use lasted 12 weeks, with follow-up to week 16. The efficacy measures were crow’s-feet grading and aesthetic-improvement scales; safety checks included adverse events and examinations. These were not imaging measurements of facial fat compartments. Its wrinkle findings cannot establish whether facial fat was preserved or reduced. [2]

The evidence boundary: this focused review did not identify a matched controlled facial LED study demonstrating unwanted facial fat loss, or a study designed to exclude it across all masks, panels and operating conditions. That is a limit of the evidence reviewed, not a claim that no relevant study could ever exist.

Why “light therapy reduces fat” is too broad

Photobiomodulation (PBM) refers to light-induced biological modulation. The term does not specify one device, exposure or anatomical target. Likewise, near-infrared (NIR) describes a spectral region; it does not, by itself, establish whether a mode is intended for skin PBM, topical heating or contouring.

There is abdominal LED evidence—but it does not settle the facial question

Nishioka and colleagues studied 90 women in sham, LED-only and LED-plus-dermocosmetic groups. A professional cluster applied 630 nm and then 850 nm light to the abdomen. Assessments extended through ten sessions and included ultrasound of the fat layer; the authors reported abdominal fat-layer reductions relative to sham. [3]

This is relevant evidence that should not be dismissed simply because it concerns LEDs. It also has important limitations: several authors were affiliated with the device manufacturer, histology came from only one participant per group, and the methods describe one abdominal side as a control while results report changes on both sides. The report does not resolve long-term persistence. None of these findings directly tests a facial mask, cheek anatomy or an unwanted facial-volume outcome. [3]

A wavelength number cannot identify the treatment mode

For a concrete document-reading example, FDA record K223544 names Guangdong Newdermo’s FM-01, FM-02 and FM-03 LED light therapy masks. It lists red light for full-face wrinkles and an infrared mode for topical heating and specified related purposes. It does not list facial fat reduction as an indication. This record is an example of mode-specific labeling, not evidence about another manufacturer’s device. [5]

FDA’s body-contouring guidance also describes nonthermal low-level-light procedures separately from heating technologies. Therefore, neither “it uses infrared” nor “it does not feel hot” is enough to settle an effect on fat. The relevant evidence must match the intended use, exposure and tissue outcome. [4]

What would count as evidence of facial fat loss?

A persuasive study would need to identify a change in facial adipose tissue and distinguish it from other changes in shape. The following is an evidence-appraisal checklist, not a universal clinical testing protocol.

• A tissue-specific endpoint: validated imaging of the relevant fat compartment or layer, with repeatable measurement locations.
• A credible comparison: an appropriate control and blinded assessment, rather than selected before-and-after examples.
• Documented exposure: the actual model, spectrum, output at the treatment position, geometry, mode and use pattern.
• Potential confounders tracked: weight changes, other procedures, medications and changes in swelling or facial expression.
• Useful follow-up: measurements capable of distinguishing a transient appearance change from a persistent tissue change.

A three-dimensional surface scan can quantify a contour change, but it does not alone identify which underlying tissue changed. “Wrinkle volume” describes the geometry of a surface feature; it is not a measurement of the fat beneath it. Even “ultrasound” needs qualification: the 2014 skin study used it for a dermal collagen endpoint, whereas the abdominal study assessed the adipose layer. The instrument name is not the outcome. [1] [3]

Common shortcuts that misread the evidence

• “It improved collagen, so fat must be protected.” These are separate tissues and endpoints.
• “A body study showed fat reduction, so a face mask must do the same.” Anatomical site and delivered exposure still need to match.
• “No serious adverse events means no possible fat change.” General safety reporting does not replace a targeted tissue measurement.
• “A cellular mechanism proves cheeks will shrink.” A biological hypothesis is not a demonstrated clinical outcome at that exposure.

If your face looks different, document the change without diagnosing it

An individual report can identify a concern worth investigating. It cannot, by itself, establish what tissue changed or prove that light caused the change. Conversely, the absence of a matching trial is not a reason to dismiss someone’s symptoms.

Useful information to bring to an assessment includes when the change began, the exact device and mode used, any discomfort or skin reaction, changes in body weight, and other recent treatments. Photo comparisons are easier to interpret when camera distance, lighting, head position and expression are consistent. Such documentation supports a consultation; it does not turn a home photograph into a fat measurement.

Do not increase exposure or deliberately repeat a treatment to test whether it caused an unwanted change. A clinician can assess the concern and decide whether examination, imaging or another evaluation is warranted.

Questions to take to the manufacturer or a clinician

Further questions

Does turning off NIR guarantee facial fat will be preserved?

No such guarantee follows from the evidence reviewed here. A red-only mode has its own delivered exposure and labeling. Removing one wavelength does not establish the safety of an otherwise unverified model or use pattern.

Does a nonthermal mode mean light cannot affect adipose tissue?

No. FDA discusses PBM as a nonthermal approach within body contouring, and the abdominal LED study reported adipose-layer changes. Neither establishes unwanted facial fat loss from a skin mask. “Nonthermal” describes a treatment characteristic, not a universal promise about every tissue outcome. [4] [3]

Can a hollowed appearance be assumed to reverse after stopping?

The reviewed evidence does not establish a recovery timetable for presumed LED-related facial fat loss. Before discussing reversibility, the change and its cause need assessment. Do not assume either permanent damage or guaranteed recovery from an online description.

Can adverse-event reports tell us how common this is?

Reports can raise a safety signal for investigation, but without verified diagnoses, exposure details and a known number of users, they cannot establish incidence or causation. A targeted study would still be needed to estimate risk for a defined device and population.

The practical conclusion

Facial fat loss is not an established outcome of the facial LED studies reviewed here. Those studies also do not justify an absolute claim that every device preserves facial fat. Evaluate the exact technology and endpoint, and have an unexplained change assessed rather than relying on a fear-based claim or a blanket reassurance.